scispace - formally typeset
D

Daniel Swinson

Researcher at Leeds Teaching Hospitals NHS Trust

Publications -  38
Citations -  1993

Daniel Swinson is an academic researcher from Leeds Teaching Hospitals NHS Trust. The author has contributed to research in topics: Performance status & Cancer. The author has an hindex of 14, co-authored 33 publications receiving 1566 citations. Previous affiliations of Daniel Swinson include University Hospitals of Leicester NHS Trust & St James's University Hospital.

Papers
More filters
Journal ArticleDOI

Feasibility of preoperative chemotherapy for locally advanced, operable colon cancer: the pilot phase of a randomised controlled trial

D. A. Agbamu, +230 more
- 25 Sep 2012 - 
TL;DR: The FOxTROT trial aims to investigate the feasibility, safety, and efficacy of preoperative chemotherapy for colon cancer, and to establish whether the encouraging pathological responses seen with preoperative therapy translates into improved long-term oncological outcome.
Journal ArticleDOI

First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials

Harpreet Wasan, +197 more
- 01 Sep 2017 - 
TL;DR: Data suggest selective internal radiotherapy (SIRT) in third-line or subsequent therapy for metastatic colorectal cancer has clinical benefit in patients with coloreCTal liver metastases with liver-dominant disease after chemotherapy.
Journal ArticleDOI

Tumour necrosis is an independent prognostic marker in non-small cell lung cancer : correlation with biological variables

TL;DR: In this paper, the prognostic implications of the extent of cancer necrosis were evaluated in non-small cell lung cancer (NSCLC) and correlated with clinicopathological variables and expression of epidermal growth factor receptor, Bcl-2, p53 and matrix metalloproteinase-9 (MMP-9).

Hypoxia-inducible factor-1α in non small cell lung cancer: Relation to growth factor, protease and apoptosis pathways

TL;DR: In this paper, the authors evaluated HIF-1α expression in 172 consecutive patients with stage I-IIIA non small cell lung cancer (NSCLC) using standard immunohistochemical techniques.